Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-05 Sale |
2025-03-07 4:13 pm |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
6,489 | $88.8 | $576,223 | 75,781 (Direct) |
View |
| 2024-10-03 Sale |
2024-10-04 5:09 pm |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
3,633 | $89.32 | $324,500 | 69,070 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 6:20 pm |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
4,377 | $90.69 | $396,950 | 72,703 (Direct) |
View |
| 2023-10-04 Sale |
2023-10-05 10:47 am |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
3,769 | $48.06 | $181,138 | 62,080 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 9:34 pm |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
1,948 | $45.68 | $88,977 | 65,849 (Direct) |
View |
| 2022-10-04 Sale |
2022-10-05 6:54 pm |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
3,477 | $67.3 | $234,002 | 52,797 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-08 4:06 pm |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
1,047 | $56.19 | $58,831 | 56,274 (Direct) |
View |
| 2021-10-05 Sale |
2021-10-07 4:26 pm |
Blueprint Medicines Corp | BPMC | Namouni Fouad President, R & D |
3,241 | $98.18 | $318,201 | 42,321 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Option Award |
2025-03-04 5:16 pm |
N/A 2035-02-28 |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
39,600 | $0 | 108,670 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 4:10 pm |
N/A 2034-05-22 |
Vor Biopharma Inc. | VOR | Namouni Fouad Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:40 pm |
N/A 2034-04-29 |
Vor Biopharma Inc. | VOR | Namouni Fouad Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-06 4:21 pm |
N/A 2034-03-01 |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
45,000 | $0 | 107,080 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:09 pm |
N/A 2033-03-01 |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
45,000 | $0 | 97,797 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:59 pm |
N/A 2032-03-01 |
Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D |
45,000 | $0 | 87,321 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-01 6:58 pm |
N/A 2031-06-30 |
Aprea Therapeutics Inc. | APRE | Namouni Fouad Director |
27,360 | $0 | 27,360 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:15 pm |
N/A 2031-03-01 |
Blueprint Medicines Corp | BPMC | Namouni Fouad President, R & D |
39,187 | $0 | 71,687 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 4:16 pm |
N/A 2030-10-01 |
Blueprint Medicines Corp | BPMC | Namouni Fouad President, R & D |
97,500 | $0 | 97,500 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-29 6:05 pm |
N/A 2030-06-26 |
Aprea Therapeutics Inc. | APRE | Namouni Fouad Director |
7,000 | $0 | 7,000 (Direct) |
View |